SAB Biotherapeutics (SABS) Asset Utilization Ratio (2021 - 2026)
SAB Biotherapeutics' Asset Utilization Ratio came in at 0.03 for Q4 2024, down 32.3% from 0.04 a year earlier but up 3.2% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
For FY2024, SAB Biotherapeutics' Asset Utilization Ratio was 0.02, down 37.8% from FY2023.
- Asset Utilization Ratio has declined in each of the last three years.
- Going back by year, Asset Utilization Ratio was 0.03 in FY2023 (-90.8%), 0.36 in FY2022 (-59.1%) and 0.88 in FY2021.
- The five-year range for quarterly Asset Utilization Ratio is 0.03 (Q3 2024) to 0.75 (Q1 2022).
- Year-over-year, Asset Utilization Ratio has declined for nine consecutive quarters, with an average decline of 72.9% over the last eight quarters.
- Across the past five years, year-over-year decline in Asset Utilization Ratio ran from 24.8% in Q4 2022 to 91.4% in Q4 2023.
- Business Quant data shows SABS's Asset Utilization Ratio at 0.03 (Q3 2024), 0.04 (Q2 2024) and 0.03 (Q1 2024) in the three quarters before Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.31 |
| 10 | SAB Biotherapeutics | 279.79 Mn | -130.87 Mn | - | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.03 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.16 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.59 |
| Jun 30, 2022 | 0.69 |
| Mar 31, 2022 | 0.75 |
| Dec 31, 2021 | 0.61 |
API Access
SAB Biotherapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();